Terms: = Kidney tumors AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Prognosis
25 results:
1. A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the AKT-mTOR signaling pathway.
Huang B; Ren J; Ma Q; Yang F; Pan X; Zhang Y; Liu Y; Wang C; Zhang D; Wei L; Ran L; Zhao H; Liang C; Wang X; Wang S; Li H; Ning H; Ran A; Li W; Wang Y; Xiao B
Mol Cancer; 2024 Feb; 23(1):34. PubMed ID: 38360682
[TBL] [Abstract] [Full Text] [Related]
2. Hereditary succinate dehydrogenase-deficient renal cell carcinoma.
Rogala J; Zhou M
Semin Diagn Pathol; 2024 Jan; 41(1):32-41. PubMed ID: 37981479
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA like NMRK2 mRNA functions as a key molecular scaffold to enhance mitochondrial respiration of NONO-TFE3 rearranged renal cell carcinoma in an NAD
Chen Y; Lu Y; Yang L; Ma W; Dong Y; Zhou S; Liu N; Gan W; Li D
J Exp Clin Cancer Res; 2023 Sep; 42(1):252. PubMed ID: 37770905
[TBL] [Abstract] [Full Text] [Related]
4. RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and EZH2 stability.
Wu Y; Xu Z; Chen X; Fu G; Tian J; Jin B
Cancer Med; 2023 Oct; 12(19):19889-19903. PubMed ID: 37747077
[TBL] [Abstract] [Full Text] [Related]
5. TROAP Promotes the Proliferation, Migration, and Metastasis of kidney Renal Clear Cell Carcinoma with the Help of STAT3.
Wang J; Wan H; Mi Y; Wu S; Li J; Zhu L
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298609
[TBL] [Abstract] [Full Text] [Related]
6. ZNF582 overexpression restrains the progression of clear cell renal cell carcinoma by enhancing the binding of TJP2 and ERK2 and inhibiting ERK2 phosphorylation.
Yang W; Zhang Z; Li L; Zhang K; Xu Y; Xia M; Zhou J; Gong Y; Chen J; Gong K
Cell Death Dis; 2023 Mar; 14(3):212. PubMed ID: 36966163
[TBL] [Abstract] [Full Text] [Related]
7. [Eosinophilic vacuolated tumor of the kidney: clinicopathological and molecular characteristics].
Zhang HZ; Xia QY; Yin XG; Wang SY
Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):437-443. PubMed ID: 35511640
[No Abstract] [Full Text] [Related]
8. Functional deficiency of succinate dehydrogenase promotes tumorigenesis and development of clear cell renal cell carcinoma through weakening of ferroptosis.
Yang J; Zhou Y; Li Y; Hu W; Yuan C; Chen S; Ye G; Chen Y; Wu Y; Liu J; Wang Y; Du J; Tong X
Bioengineered; 2022 Apr; 13(4):11187-11207. PubMed ID: 35510387
[TBL] [Abstract] [Full Text] [Related]
9. Claudin-10 overexpression suppresses human clear cell renal cell carcinoma growth and metastasis by regulating ATP5O and causing mitochondrial dysfunction.
Yang W; Zhang K; Zhang Z; Zhou J; Li L; Xu Y; Qiu J; Cai L; Gong Y; Gong K
Int J Biol Sci; 2022; 18(6):2329-2344. PubMed ID: 35414767
[TBL] [Abstract] [Full Text] [Related]
10. A Novel Pyroptosis-Related Prognostic Signature for Risk Stratification and Clinical prognosis in Clear Cell Renal Cell Carcinoma.
Pan XQ; Huang W; Jin LW; Lin HZ; Xu XY
Dis Markers; 2022; 2022():8093837. PubMed ID: 35308143
[TBL] [Abstract] [Full Text] [Related]
11. [Succinate dehydrogenase-deficient renal cell carcinoma:a clinicopathological, ultrastructural and molecular analysis].
Wang XT; Wang X; Zhang RS; Cheng K; Xia QY; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):12-16. PubMed ID: 34979747
[No Abstract] [Full Text] [Related]
12. Hypopituitarism in patients with metastatic renal cell carcinoma treated with ipilimumab and nivolumab combination therapy.
Takagi T; Yoshida K; Kondo T; Fukuda H; Ishihara H; Kobayashi H; Iizuka J; Ishida H; Tanabe K
Jpn J Clin Oncol; 2021 Dec; 51(12):1744-1750. PubMed ID: 34487184
[TBL] [Abstract] [Full Text] [Related]
13. METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression.
Liu Z; Sun T; Piao C; Zhang Z; Kong C
J Transl Med; 2021 May; 19(1):209. PubMed ID: 33985542
[TBL] [Abstract] [Full Text] [Related]
14. [Histological subtypes of renal cell carcinoma : Overview and new developments].
Polifka I; Agaimy A; Moch H; Hartmann A
Pathologe; 2021 May; 42(3):294-304. PubMed ID: 33825093
[TBL] [Abstract] [Full Text] [Related]
15. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Trpkov K; Hes O; Williamson SR; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Gill AJ
Mod Pathol; 2021 Jul; 34(7):1392-1424. PubMed ID: 33664427
[TBL] [Abstract] [Full Text] [Related]
16. Ancestry-specific predisposing germline variants in cancer.
Oak N; Cherniack AD; Mashl RJ; ; Hirsch FR; Ding L; Beroukhim R; Gümüş ZH; Plon SE; Huang KL
Genome Med; 2020 May; 12(1):51. PubMed ID: 32471518
[TBL] [Abstract] [Full Text] [Related]
17. Therapeutic Targeting of
Liu Y; Pang Y; Zhu B; Uher O; Caisova V; Huynh TT; Taieb D; Hadrava Vanova K; Ghayee HK; Neuzil J; Levine M; Yang C; Pacak K
Clin Cancer Res; 2020 Jul; 26(14):3868-3880. PubMed ID: 32152203
[TBL] [Abstract] [Full Text] [Related]
18. Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma.
Wang C; Wang Y; Hong T; Cheng B; Gan S; Chen L; Zhang J; Zuo L; Li J; Cui X
Cell Death Dis; 2020 Feb; 11(2):117. PubMed ID: 32051393
[TBL] [Abstract] [Full Text] [Related]
19. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma.
Tsai TH; Lee WY
Arch Pathol Lab Med; 2019 May; 143(5):643-647. PubMed ID: 31026220
[TBL] [Abstract] [Full Text] [Related]
20. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL
Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535
[TBL] [Abstract] [Full Text] [Related]
[Next]